AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Buy” from Analysts
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned a consensus rating of “Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have covered the stock in the last year […]
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned a consensus rating of “Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have covered the stock in the last year […]
